1973Journal of Radiation ResearchRequires access

Radiosensitivity of Ehrlich Ascites Tumor Cells in Different Growth Phases and its Enhancement by lodoacetamide

Noritaka Tanaka

Open publisher page 1 citations

Abstract

The x-ray survival curve of Ehrlich ascites tumor cells and its modification by iodoacetamide were determined by the TD50, assay. Survival curves for tumor cells of 1, 6 and 12-days after transplantation were examined in the presenc or in the absence of the agent. The D0 was 130, 350 or 230 rads for 1-, 6 and 12-day-old tumor cells, respectively. The response to x-rays of 1 and 6-day-old tumor cells was enhanced by iodoacetamide, while that of 12-day-old or stationary phase tumor cells was hardly enhanced. The increased radiosensitivity and the lowered sensitization by iodoacetamide of 12-day-old tumor cells might be attributed to an increased proportron of the stationary phase cells.

About this research paper

What this paper is about

The x-ray survival curve of Ehrlich ascites tumor cells and its modification by iodoacetamide were determined by the TD50, assay. Survival curves for tumor cells of 1, 6 and 12-days after transplantation were examined in the presenc or in the absence of the agent. The D0 was 130, 350 or 230 rads for 1-, 6 and 12-day-old tumor cells, respectively. The response to x-rays of 1 and 6-day-old tumor cells was enhanced by iodoacetamide, while that of 12-day-old or stationary phase tumor cells was hardly enhanced. The increased radiosensitivity and the lowered sensitization by iodoacetamide of 12-day-old tumor cells might be attributed to an increased proportron of the stationary phase cells.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The x-ray survival curve of Ehrlich ascites tumor cells and its modification by iodoacetamide were determined by the TD50, assay. Survival curves for tumor cells of 1, 6 and 12-days after transplantation were examined in the presenc or in the absence of the agent. The D0 was 130, 350 or 230 rads for 1-, 6 and 12-day-old tumor cells, respectively. The response to x-rays of 1 and 6-day-old tumor cells was enhanced by iodoacetamide, while that of 12-day-old or stationary phase tumor cells was hardly enhanced. The increased radiosensitivity and the lowered sensitization by iodoacetamide of 12-day-old tumor cells might be attributed to an increased proportron of the stationary phase cells.

Key concepts: Iodoacetamide, Radiosensitivity, Tumor cells, Ascites, Transplantation, Sensitization, Ehrlich ascites, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Radiosensitivity of Ehrlich Ascites Tumor Cells in Different Growth Phases and its Enhancement by lodoacetamide — Research Paper | ScholarLens